Test 6 Preliminary validation of a structural magnetic resonance imaging metric for tracking dementia-related neurodegeneration and future decline
Gavin T Kress 1, Emily S Popa 2, Paul M Thompson 3, Susan Y Bookheimer 4, Sophia I Thomopoulos 3, Christopher R K Ching 3, Hong Zheng 3, Daniel A Hirsh 5, David A Merrill 6, Stella E Panos 2, Cyrus A Raji 7, Prabha Siddarth 8, Jennifer E Bramen 9 Affiliations Expand Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline…